Englander Institute for Precision Medicine

Publications

Found 125 results
Author Title Type [ Year(Asc)]
Filters: Author is Galluzzi, Lorenzo  [Clear All Filters]
2020
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez ABuqué, Chan TA, Coukos G, Demaria S, Deutsch E et al..  2020.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.. J Immunother Cancer. 8(1)
Pilones KA, Hensler M, Daviaud C, Kraynak J, Fucikova J, Galluzzi L, Demaria S, Formenti SC.  2020.  Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.. Oncoimmunology. 9(1):1830524.
Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L.  2020.  Detection of immunogenic cell death and its relevance for cancer therapy.. Cell Death Dis. 11(11):1013.
Yamazaki T, Vanpouille-Box C, Demaria S, Galluzzi L.  2020.  Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment.. Cancer Treat Res. 180:281-296.
Galluzzi L, Petroni G, Kroemer G.  2020.  Immunogenicity of cell death driven by immune effectors.. J Immunother Cancer. 8(1)
Rodriguez-Ruiz MEsperanza, Vitale I, Harrington KJ, Melero I, Galluzzi L.  2020.  Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.. Nat Immunol. 21(2):120-134.
Petroni G, Formenti SC, Chen-Kiang S, Galluzzi L.  2020.  Immunomodulation by anticancer cell cycle inhibitors.. Nat Rev Immunol. 20(11):669-679.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A et al..  2020.  Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.. Nat Commun. 11(1):3819.
Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G.  2020.  Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.. Nat Rev Clin Oncol. 17(12):725-741.
Rendeiro AF, Casano J, Vorkas CKyriakos, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K et al..  2020.  Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression.. medRxiv.
Hensler M, Kasikova L, Fiser K, Rakova J, Skapa P, Laco J, Lanickova T, Pecen L, Truxova I, Vosahlikova S et al..  2020.  M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer.. J Immunother Cancer. 8(2)
Yamazaki T, Galluzzi L.  2020.  Mitochondrial control of innate immune signaling by irradiated cancer cells.. Oncoimmunology. 9(1):1797292.
Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Manzano ENavarro et al..  2020.  Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.. Nat Immunol. 21(10):1160-1171.
Buqué A, Bloy N, Petroni G, Kroemer G, Galluzzi L.  2020.  NK cells beat T cells at early breast cancer control.. Oncoimmunology. 9(1):1806010.
Chong SJun Fei, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S.  2020.  Noncanonical Cell Fate Regulation by Bcl-2 Proteins.. Trends Cell Biol. 30(7):537-555.
Yamazaki T, Buqué A, Ames TD, Galluzzi L.  2020.  PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models.. Oncoimmunology. 9(1):1721810.
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A et al..  2020.  Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.. Nat Commun. 11(1):4787.
Petroni G, Galluzzi L.  2020.  Senescence Inflames the Pancreatic Tumor Microenvironment.. Cell Rep Med. 1(2):100020.
Galluzzi L.  2020.  Targeting Mutant KRAS for Immunogenic Cell Death Induction.. Trends Pharmacol Sci. 41(1):1-3.
Galluzzi L, Kroemer G.  2020.  Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? Trends Cell Biol. 30(5):339-340.
Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L et al..  2020.  Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.. Oncoimmunology. 9(1):1703449.
Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O.  2020.  Trial Watch: experimental TLR7/TLR8 agonists for oncological indications.. Oncoimmunology. 9(1):1796002.
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E.  2020.  Trial watch: IDO inhibitors in cancer therapy.. Oncoimmunology. 9(1):1777625.
Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G.  2020.  Trial watch: STING agonists in cancer therapy.. Oncoimmunology. 9(1):1777624.
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E.  2020.  Trial watch: TLR3 agonists in cancer therapy.. Oncoimmunology. 9(1):1771143.